financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Amrize Ag
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Amrize Ag
Jul 15, 2025 10:21 PM

01:00 AM EDT, 07/16/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We maintain our Buy rating on AMRZ, due to a compelling valuation opportunity as the stock trades at a severe discount to peers despite comparable end-market exposure and superior competitive positioning. The company's market-leading positions as North America's largest cement producer and #2 commercial roofing company create defensive moats that justify peer-level valuations, yet the market appears to overly discount the recent spin-off. While synchronized construction weakness creates near-term headwinds across the sector, AMRZ's exceptional valuation discount offers attractive risk-adjusted returns should fundamentals stabilize. We lift our 12-month target price by $3 to $60, on an EV/EBITDA of 13.0x our 2025 EBITDA estimate, in line with weighted peer averages based on end-market similarity: EXP (9.6x, 25.3% weight), VMC (15.8x, 25.3% weight), MLM (15.1x, 30.8% weight), and CRH (10.2x, 18.6% weight). We lower our 2025 EPS estimate by $0.28 to $2.35 and 2026 by $0.04 to $2.98 to reflect sector headwinds.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Retains Buy Opinion On Shares Of Amgen Inc.
Research Alert: CFRA Retains Buy Opinion On Shares Of Amgen Inc.
May 3, 2024
10:00 AM EDT, 05/03/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Amgen ( AMGN ) reported Q1 earnings yesterday after market close. We lift our target price to $357 from $352, 16.8x our 2025 EPS, slightly above AMGN's historical forward P/E...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Coinbase Global, Inc.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Coinbase Global, Inc.
May 3, 2024
09:55 AM EDT, 05/03/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our price target by $39 to $234 on EV/sales of 13.0x our 2024 sales estimate. We raise our 2024 EPS estimate by $5.05 to $7.60 and 2025's by...
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Federal Realty Investment Trust
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Federal Realty Investment Trust
May 3, 2024
10:05 AM EDT, 05/03/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our price target at $119, using a forward P/FFO of 17.5x our 2024 FFO estimate, a premium to retail REIT peers (12.3x) due to FRT's best-in-class portfolio of...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Cbre Group, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Cbre Group, Inc.
May 3, 2024
10:25 AM EDT, 05/03/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our target by $10 to $86, applying a forward P/E of 20.0x our 2024 EPS estimate, a premium to CBRE's ( CBRE ) 10-year average multiple of 16.5x...
Copyright 2023-2026 - www.financetom.com All Rights Reserved